JP2018520170A5 - - Google Patents

Download PDF

Info

Publication number
JP2018520170A5
JP2018520170A5 JP2018500737A JP2018500737A JP2018520170A5 JP 2018520170 A5 JP2018520170 A5 JP 2018520170A5 JP 2018500737 A JP2018500737 A JP 2018500737A JP 2018500737 A JP2018500737 A JP 2018500737A JP 2018520170 A5 JP2018520170 A5 JP 2018520170A5
Authority
JP
Japan
Prior art keywords
pyrrolo
pyridin
ethanone
methyl
fluoro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018500737A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018520170A (ja
JP6964576B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/041339 external-priority patent/WO2017007938A1/en
Publication of JP2018520170A publication Critical patent/JP2018520170A/ja
Publication of JP2018520170A5 publication Critical patent/JP2018520170A5/ja
Priority to JP2021138906A priority Critical patent/JP7369743B2/ja
Application granted granted Critical
Publication of JP6964576B2 publication Critical patent/JP6964576B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018500737A 2015-07-09 2016-07-07 置換4−アザインドール及びglun2b受容体調節因子としてのそれらの使用 Active JP6964576B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2021138906A JP7369743B2 (ja) 2015-07-09 2021-08-27 置換4-アザインドール及びglun2b受容体調節因子としてのそれらの使用

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562190416P 2015-07-09 2015-07-09
US62/190,416 2015-07-09
PCT/US2016/041339 WO2017007938A1 (en) 2015-07-09 2016-07-07 Substituted 4-azaindoles and their use as glun2b receptor modulators

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021138906A Division JP7369743B2 (ja) 2015-07-09 2021-08-27 置換4-アザインドール及びglun2b受容体調節因子としてのそれらの使用

Publications (3)

Publication Number Publication Date
JP2018520170A JP2018520170A (ja) 2018-07-26
JP2018520170A5 true JP2018520170A5 (enExample) 2019-07-25
JP6964576B2 JP6964576B2 (ja) 2021-11-10

Family

ID=56497884

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2018500737A Active JP6964576B2 (ja) 2015-07-09 2016-07-07 置換4−アザインドール及びglun2b受容体調節因子としてのそれらの使用
JP2021138906A Active JP7369743B2 (ja) 2015-07-09 2021-08-27 置換4-アザインドール及びglun2b受容体調節因子としてのそれらの使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2021138906A Active JP7369743B2 (ja) 2015-07-09 2021-08-27 置換4-アザインドール及びglun2b受容体調節因子としてのそれらの使用

Country Status (25)

Country Link
US (2) US9963447B2 (enExample)
EP (1) EP3319963B1 (enExample)
JP (2) JP6964576B2 (enExample)
KR (1) KR20180026760A (enExample)
CN (1) CN108026094B (enExample)
AU (1) AU2016291158B2 (enExample)
BR (1) BR112018000468A2 (enExample)
CA (1) CA2991765C (enExample)
CY (1) CY1123007T1 (enExample)
DK (1) DK3319963T3 (enExample)
EA (1) EA033197B1 (enExample)
ES (1) ES2781867T3 (enExample)
HR (1) HRP20200410T1 (enExample)
HU (1) HUE047460T2 (enExample)
IL (1) IL256758A (enExample)
LT (1) LT3319963T (enExample)
MA (1) MA42397B1 (enExample)
MD (1) MD3319963T2 (enExample)
MX (1) MX2018000352A (enExample)
PL (1) PL3319963T3 (enExample)
PT (1) PT3319963T (enExample)
SI (1) SI3319963T1 (enExample)
SM (1) SMT202000134T1 (enExample)
WO (1) WO2017007938A1 (enExample)
ZA (1) ZA201800827B (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10155727B2 (en) 2014-08-15 2018-12-18 Janssen Pharmaceuticals, Inc. Pyrazoles
WO2016025917A1 (en) 2014-08-15 2016-02-18 Janssen Pharmaceuticals, Inc. Triazoles as nr2b receptor inhibitors
AU2016291158B2 (en) 2015-07-09 2020-04-30 Janssen Pharmaceutica Nv Substituted 4-azaindoles and their use as GluN2B receptor modulators
US10071988B2 (en) 2016-02-10 2018-09-11 Janssen Pharmaceutica Nv Substituted 1,2,3-triazoles as NR2B-selective NMDA modulators
TW201819376A (zh) 2016-10-06 2018-06-01 比利時商健生藥品公司 經取代之1H-咪唑並[4,5-b]吡啶-2(3H)-酮及其作為GLUN2B受體調節劑之用途
WO2019193516A2 (en) * 2018-04-04 2019-10-10 Janssen Pharmaceutica Nv Substituted pyridine and pyrimidines and their use as glun2b receptor modulators
TW202112774A (zh) 2019-06-14 2021-04-01 比利時商健生藥品公司 經取代之吡唑并-吡啶醯胺及其作為glun2b受體調節劑之用途
AU2020293642A1 (en) * 2019-06-14 2022-01-20 Janssen Pharmaceutica Nv Substituted pyrazolo[4,3-b]pyridines and their use as GluN2B receptor modulators
CA3143103A1 (en) 2019-06-14 2020-12-17 Janssen Pharmaceutica Nv Pyridine carbamates and their use as glun2b receptor modulators
MX2021015511A (es) 2019-06-14 2022-01-31 Janssen Pharmaceutica Nv Carbamatos de pirazina y sus usos como moduladores del receptor glun2b.
JP7667097B2 (ja) * 2019-06-14 2025-04-22 ヤンセン ファーマシューティカ エヌ.ベー. 置換ピラゾロ-ピリジンアミド及びglun2b受容体調節因子としてのその使用
BR112021025141A2 (pt) 2019-06-14 2022-01-25 Janssen Pharmaceutica Nv Pirazolo-piridinas heteroaromáticas substituídas e seu uso como moduladores do receptor glun2b
CN114008052A (zh) * 2019-06-14 2022-02-01 詹森药业有限公司 取代的吡唑并-吡嗪以及它们作为GluN2B受体调节剂的用途
CN114621125B (zh) * 2020-12-14 2024-07-09 中国科学技术大学 Nlrp3炎症小体抑制剂及其应用

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60316542T2 (de) * 2002-03-28 2008-07-03 Eisai R&D Management Co., Ltd. 7-azaindole als inhibitoren c-jun n-terminaler kinasen zur behandlung neurodegenerativer störungen
RU2006127575A (ru) 2004-02-18 2008-03-27 Астразенека Аб (Se) Соединение триазола и их применение в качестве антагонистов метаботропного рецептора глутамата
US20060183758A1 (en) * 2005-02-17 2006-08-17 Cb Research And Development, Inc. Method for synthesis of AZA-annelated pyrroles, thiophenes, and furans
WO2007115231A2 (en) * 2006-03-30 2007-10-11 Chemocentryx, Inc. Cxcr4 modulators
PE20090717A1 (es) * 2007-05-18 2009-07-18 Smithkline Beecham Corp Derivados de quinolina como inhibidores de la pi3 quinasa
EP2167464B1 (en) 2007-05-25 2014-12-03 AbbVie Deutschland GmbH & Co KG Heterocyclic compounds as positive modulators of metabotropic glutamate receptor 2 (mglu2 receptor)
WO2009005821A1 (en) 2007-07-03 2009-01-08 Edward Scott Carlson Support apparatus for climbing plants
JPWO2009028543A1 (ja) 2007-08-30 2010-12-02 武田薬品工業株式会社 置換ピラゾール誘導体
EP2215073A4 (en) 2007-10-31 2011-04-06 Merck Sharp & Dohme SLEEP MODULATION WITH NR2B RECEPTOR ANTAGONISTS
MX2010009649A (es) 2008-03-27 2010-12-17 Evotecv Neurosciences Gmbh Metodos para tratar trastornos utilizando un antagonista selectivo del subtipo nr2b de nmda.
BRPI0917540A2 (pt) 2008-08-05 2015-11-17 Daiichi Sankyo Co Ltd composto, sal farmacologicamente aceitavél, composição farmacêutica, e, uso de um composto ou sal farmacologicamente aceitável
WO2010043396A1 (en) * 2008-10-16 2010-04-22 Ortho-Mcneil-Janssen Pharmaceuticals, Inc. Indole and benzomorpholine derivatives as modulators of metabotropic glutamate receptors
WO2010068483A2 (en) 2008-11-25 2010-06-17 University Of Rochester Mlk inhibitors and methods of use
TWI598347B (zh) * 2009-07-13 2017-09-11 基利科學股份有限公司 調節細胞凋亡信號之激酶的抑制劑
EP2579717A4 (en) 2010-06-09 2013-12-11 Merck Sharp & Dohme POSITIVE ALLOSTERIC MODULATORS OF MGLUR2
WO2013130855A1 (en) 2012-03-02 2013-09-06 Takeda Pharmaceutical Company Limited Indazole derivatives
WO2014124651A1 (en) * 2013-02-15 2014-08-21 Københavns Universitet Pyrrolidine-2-carboxylic acid derivatives as iglur antagonists
EP2970200A1 (en) * 2013-03-13 2016-01-20 Abbvie Inc. Pyridine cdk9 kinase inhibitors
DK2970265T3 (en) * 2013-03-15 2018-10-01 Plexxikon Inc HETEROCYCLIC COMPOUNDS AND APPLICATIONS THEREOF
CN103626767A (zh) * 2013-12-04 2014-03-12 上海药明康德新药开发有限公司 区域选择性的氮杂吲哚及其合成方法
WO2016025917A1 (en) 2014-08-15 2016-02-18 Janssen Pharmaceuticals, Inc. Triazoles as nr2b receptor inhibitors
US10155727B2 (en) 2014-08-15 2018-12-18 Janssen Pharmaceuticals, Inc. Pyrazoles
AU2016291158B2 (en) * 2015-07-09 2020-04-30 Janssen Pharmaceutica Nv Substituted 4-azaindoles and their use as GluN2B receptor modulators
US10071988B2 (en) 2016-02-10 2018-09-11 Janssen Pharmaceutica Nv Substituted 1,2,3-triazoles as NR2B-selective NMDA modulators
TW201819376A (zh) 2016-10-06 2018-06-01 比利時商健生藥品公司 經取代之1H-咪唑並[4,5-b]吡啶-2(3H)-酮及其作為GLUN2B受體調節劑之用途

Similar Documents

Publication Publication Date Title
JP2018520170A5 (enExample)
HRP20200410T1 (hr) Supstituirani 4-azaindoli i njihova upotreba kao modulatora glun2b receptora
JP2019530695A5 (enExample)
JP2016523911A5 (enExample)
JP2011500806A5 (enExample)
JP7609854B2 (ja) Magl阻害剤としての4,4a,5,7,8,8a-ヘキサピリド[4,3-b][1,4]オキサジン-3-オン化合物
CN116531380B (zh) 用于治疗癌症的2-杂芳基-3-氧代-2,3-二氢哒嗪-4-甲酰胺
JP2021533093A (ja) モノアシルグリセロールリパーゼ阻害剤としての新規複素環化合物
JP4638355B2 (ja) チアゾール誘導体
JP2022536174A5 (enExample)
JP2016519156A5 (enExample)
JP2017502049A5 (enExample)
RU2021133444A (ru) Производные бензимидазола в качестве модуляторов ror-гамма
CN107624111A (zh) 作为激酶抑制剂的杂环酰胺
CN104024250B (zh) 作为痕量胺相关受体(taar)的杂环衍生物
US9809573B2 (en) Substituted pyridine derivatives useful as GSK-3 inhibitors
JP2019523233A5 (enExample)
JP2016523925A5 (enExample)
IL263511A (en) 1h-pyrazolo[4,3-b]pyridines as pde1 inhibitors
JP2017500364A5 (enExample)
JP2017528515A5 (enExample)
RU2016112952A (ru) Производные индола и индазола
IL294504A (en) Converted pyrazolo-pyrimidines and their uses
JP2020503302A5 (enExample)
JP6255516B2 (ja) モルホリン−ピリジン誘導体